Top Healthcare Companies in USA List by Market Cap as of August 2026

Top Healthcare Companies in USA List by Market Cap as of August 2026. Biggest and Top Healthcare Companies in USA Companies by Market Cap. Largest Top Healthcare Companies in USA List by Market Cap as of August 2026.
Top Healthcare Companies in USA
Top Healthcare Companies in USA, Biggest Healthcare Companies in USA, Largest Healthcare Companies in USA.

  1. Aimmune Therapeutics

    World Rank (Aug-2026)
    4,918
    World Rank (Jan-05-2024)
    4,918
    World Rank (Jul-30-2023)
    4,918
    World Rank (Dec-25-2022)
    4,918
    World Rank (Jan-07-2022)
    4,918
    Annual Operating Income in USD
    -250 Million USD
    Annual Net Income in USD
    -248 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile
    Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies. Headquarters is in USA.
    Company Website
    AIMMUNE THERAPEUTICS INC

  2. Brookdale Senior Living

    World Rank (Aug-2026)
    5,025
    Market Cap (Aug-2026)
    3.019 Billion USD
    World Rank (Jan-05-2024)
    8,248
    Market Cap (Jan-05-2024)
    1.073 Billion USD
    World Rank (Jul-30-2023)
    11,039
    Market Cap (Jul-30-2023)
    0.657 Billion USD
    World Rank (Dec-25-2022)
    12,318
    Market Cap (Dec-25-2022)
    0.506 Billion USD
    World Rank (Jan-07-2022)
    9,586
    Market Cap (Jan-07-2022)
    0.97 Billion USD
    Annual Revenue in USD
    3,194 Million USD
    Annual Operating Income in USD
    13 Million USD
    Annual Net Income in USD
    -263 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ NYSE
    Company Profile
    Brookdale Senior Living is a Facilities, Potential Solutions and Options company. It is having 741 retirement communities serving around 65,000 residents and with a wide range of innovative programs and services as on 2020. The company also offer a range of home health, hospice and outpatient therapy services to around 20,000 patients as of that date. The headquarters is in USA.
    Company Website
    BROOKDALE SENIOR LIVING INC

  3. Acadia Healthcare Company

    World Rank (Aug-2026)
    5,173
    Market Cap (Aug-2026)
    2.870 Billion USD
    World Rank (Jan-05-2024)
    2,180
    Market Cap (Jan-05-2024)
    7.222 Billion USD
    World Rank (Jul-30-2023)
    2,166
    Market Cap (Jul-30-2023)
    7.309 Billion USD
    World Rank (Dec-25-2022)
    1,920
    Market Cap (Dec-25-2022)
    7.551 Billion USD
    World Rank (Jan-07-2022)
    3,247
    Market Cap (Jan-07-2022)
    5.07 Billion USD
    Annual Revenue in USD
    3,313 Million USD
    Annual Net Income in USD
    -1,103 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Acadia Healthcare business is treatment of behavioral health and addiction concerns. Headquarters is in Tennessee, USA.

    Acadia Healthcare owns and operates treatment facilities in nearly 600 cities throughout the United States, Puerto Rico and UK.

    Facts About Company

    As on 2022, Acadia Healthcare had 23,000 employees.

    For year ending Dec-2022, Acadia Healthcare annual revenue was 2,610 million USD and annual operating income was 467 million USD and annual net income was 273 million USD.

    Company Website
    ACADIA HEALTHCARE COMPANY
    Wikipedia
    Wikipedia

  4. Supernus Pharmaceuticals

    World Rank (Aug-2026)
    5,237
    Market Cap (Aug-2026)
    2.806 Billion USD
    World Rank (Jan-05-2024)
    6,703
    Market Cap (Jan-05-2024)
    1.522 Billion USD
    World Rank (Jul-30-2023)
    6,453
    Market Cap (Jul-30-2023)
    1.657 Billion USD
    World Rank (Dec-25-2022)
    5,403
    Market Cap (Dec-25-2022)
    2.026 Billion USD
    World Rank (Jan-07-2022)
    7,241
    Market Cap (Jan-07-2022)
    1.58 Billion USD
    Annual Revenue in USD
    719 Million USD
    Annual Operating Income in USD
    -62 Million USD
    Annual Net Income in USD
    -39 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    Supernus Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases. The company annual revenue is 392.8 million USD and 464 employees as on 2019. The headquarters is in USA.
    Company Website
    SUPERNUS PHARMACEUTICALS INC

  5. Momenta Pharmaceuticals

    World Rank (Aug-2026)
    5,297
    World Rank (Jan-05-2024)
    5,297
    World Rank (Jul-30-2023)
    5,297
    World Rank (Dec-25-2022)
    5,297
    World Rank (Jan-07-2022)
    5,297
    Annual Revenue in USD
    24 Million USD
    Annual Operating Income in USD
    -298 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile

    Momenta Pharmaceuticals is a Biotechnology company. The headquarters is in USA.

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD.

    Facts About Company

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD

    Company Website
    MOMENTA PHARMACEUTICALS INC

  6. Nuvasive

    World Rank (Aug-2026)
    5,412
    World Rank (Jan-05-2024)
    5,412
    World Rank (Jul-30-2023)
    5,412
    Market Cap (Jul-30-2023)
    2.199 Billion USD
    World Rank (Dec-25-2022)
    5,324
    Market Cap (Dec-25-2022)
    2.075 Billion USD
    World Rank (Jan-07-2022)
    5,223
    Market Cap (Jan-07-2022)
    2.70 Billion USD
    Annual Revenue in USD
    1,202 Million USD
    Annual Net Income in USD
    40 Million USD
    Annual Results for Period Ending
    For year ending December-2022
    Headquarters Country
    USA
    Company Profile

    NuVasive is a Healthcare company. It is estimated 10 million U.S. adults suffer from chronic back pain each year which creates the third highest spend in U.S. healthcare. The company support includes online learning ,live clinical observation, case support and peer education. The headquarters is in USA.

    In 2019, they achieved 1.168 billion USD in full-year revenue and it has 2,800 employees.

    Company Website
    NUVASIVE INC

  7. Curaleaf Holdings

    World Rank (Aug-2026)
    5,427
    Market Cap (Aug-2026)
    2.640 Billion USD
    World Rank (Jan-05-2024)
    4,281
    Market Cap (Jan-05-2024)
    3.093 Billion USD
    World Rank (Jul-30-2023)
    4,927
    Market Cap (Jul-30-2023)
    2.505 Billion USD
    World Rank (Dec-25-2022)
    4,010
    Market Cap (Dec-25-2022)
    3.075 Billion USD
    World Rank (Jan-07-2022)
    2,855
    Market Cap (Jan-07-2022)
    5.93 Billion USD
    Annual Revenue in USD
    1,268 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ OTC
    Company Profile

    Curaleaf Holdings is a Cannabis company. Curaleaf has a presence in 23 states, owns and operates 101 dispensaries, 23 cultivation sites, and 30 processing sites with a focus on highly populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. The headquarters is in USA.

    Company Website
    CURALEAF HOLDINGS
    Wikipedia
    Wikipedia

  8. Portola Pharmaceuticals

    World Rank (Aug-2026)
    5,432
    World Rank (Jan-05-2024)
    5,432
    World Rank (Jul-30-2023)
    5,432
    World Rank (Dec-25-2022)
    5,432
    World Rank (Jan-07-2022)
    5,432
    Annual Revenue in USD
    117 Million USD
    Annual Operating Income in USD
    -271 Million USD
    Annual Net Income in USD
    -291 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    USA
    Company Profile

    Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.

  9. Axogen

    World Rank (Aug-2026)
    5,456
    Market Cap (Aug-2026)
    2.620 Billion USD
    World Rank (Jan-05-2024)
    15,954
    Market Cap (Jan-05-2024)
    0.291 Billion USD
    World Rank (Jul-30-2023)
    14,713
    Market Cap (Jul-30-2023)
    0.365 Billion USD
    World Rank (Dec-25-2022)
    13,575
    Market Cap (Dec-25-2022)
    0.420 Billion USD
    World Rank (Jan-07-2022)
    14,686
    Market Cap (Jan-07-2022)
    0.41 Billion USD
    Annual Revenue in USD
    225 Million USD
    Annual Operating Income in USD
    -8 Million USD
    Annual Net Income in USD
    -16 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Axogen is a company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. The headquarters is in USA.
    Facts About Company
    Axogen company annual revenue was 138 million USD and annual net loss was -28 million USD as on Dec-2022.
    Company Website
    AXOGEN

  10. Ultragenyx Pharmaceutical

    World Rank (Aug-2026)
    5,466
    Market Cap (Aug-2026)
    2.612 Billion USD
    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    673 Million USD
    Annual Operating Income in USD
    -535 Million USD
    Annual Net Income in USD
    -575 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

    Company Website
    ULTRAGENYX PHARMACEUTICAL INC

Share